GlassScriptPhysician profile
Shoaib M Safiullah
NPI 1578084349
$14,418.13
in general payments reported to CMS, 2019-2025
39 companies · $4,035 in 2025
The $4,035 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $83.17 · 2021: $834 · 2022: $3,333 · 2023: $2,919 · 2024: $2,951 · 2025: $4,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,645 · Travel and Lodging: $4,181 · Education: $78.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,645.30 |
| Travel and Lodging | $4,180.96 |
| Education | $78.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,915.57 | 2020-2025 | Lumenis Pulse 120h, Axonics, Ams 700 |
| Teleflex LLC | $1,051.89 | 2022-2024 | Urolift |
| Uromedica, Incorporated | $1,015.66 | 2025 | Proact |
| Abbvie INC. | $342.25 | 2023-2025 | Lupron Depot, Botox |
| Medtronic, INC. | $341.64 | 2021-2025 | Altaviva, Interstim |
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Astellas Pharma US INC | $298.04 | 2021-2024 | Xtandi |
| Pfizer INC. | $291.07 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $287.85 | 2023-2025 | Orgovyx |
| Procept Biorobotics Corporation | $278.27 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Calyxo, INC. | $220.34 | 2024-2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $216.79 | 2024-2025 | Adstiladrin |
| Axonics, INC. | $184.88 | 2024 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $174.78 | 2022-2025 | |
| Antares Pharma, INC. | $171.45 | 2022-2025 | Xyosted, Tlando, Nocdurna |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $165.34 | 2022-2025 | Titan, Porges Coloplast, Speedicath |
| Janssen Biotech, INC. | $155.18 | 2023-2025 | Erleada, Akeega |
| Cook Medical LLC | $135.56 | 2019 | |
| Medtronic USA, INC. | $127.71 | 2019 | |
| Progenics Pharmaceuticals, INC. | $97.97 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $74.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $70.26 | 2024-2025 | |
| Baxter Healthcare | $65.05 | 2023-2024 | Floseal, Tisseel |
| Endo Pharmaceuticals INC. | $57.42 | 2023-2024 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $45.74 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $44.66 | 2023-2025 | Jelmyto |
| Olympus America INC. | $38.51 | 2023-2025 | Itind System |
| Endo USA, INC. | $38.15 | 2024-2025 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $27.60 | 2023 | |
| Myriad Genetic Laboratories, INC. | $26.64 | 2023-2024 | Prolaris |
| C. R. Bard, INC. & Subsidiaries | $22.55 | 2025 | Bard Urinary Drainage Bag |
| Tempus Ai, INC | $19.81 | 2024 | |
| Inspire Medical Systems, INC. | $17.48 | 2025 | Inspire |
| Halozyme INC | $17.01 | 2023 | |
| Acerus Pharmaceuticals Corporation | $16.49 | 2022 | |
| Smith+Nephew, INC. | $16.20 | 2025 | Stravix Pl |
| Ethicon US, LLC | $15.49 | 2022 | |
| Dendreon Pharmaceuticals LLC | $14.55 | 2024 | Provenge |
| Myovant Sciences INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shoaib Safiullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.